Back to FMR LLC FMR LLC

ORTXORTX
4 quarters

Position history for FMR LLCFMR LLC's holdings in ORCHARD THERAPEUTICS PLC

As of its Q4 2023 13F, FMR held 41,228 shares of ORTX (Orchard Therapeutics), worth $678,201. FMR's 13F filings listed ORTX from Q2 2023 to Q4 2023, 3 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$213,973

Total Shares Change

-41,228

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q1
Latest
Exited
0
-100.0%
$00.0%—
0
2023-Q4
Unchanged
41,228
0.0%
$678,2010.0%—
0
2023-Q3
Unchanged
41,228
0.0%
$319,9290.0%—
0
2023-Q2
New
41,228
-
$213,9730.0%—
35

Other major holders of ORTX: FEDERATED HERMES, INC., LMR Partners LLP, TUDOR INVESTMENT CORP ET AL

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used